IRINOTECAN QILU

Concentrate for solution for infusion, 40mg/2ml
RxActive license

Active substance (INN)

irinotecan

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength40mg/2ml
PackagingUkupno 1 bočica staklena sa 2ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerKymos, Spain
Therapeutic groupAntineoplastic and immunomodulating agents (L01CE02)
Marketing authorization holderDRUŠTVO ZA TRGOVINU, PROMET I USLUGE "PONTERA PHARMA SOLUTIONS" DOO PODGORICA
Authorization dateMarch 1, 2024

Analogs in Montenegro

7

Other medicines with the same active substance

IRINOTECAN ACCORDRx
Concentrate for solution for infusion, 20mg/mlAccord Healthcare Polska Sp. z o.o. Magazyn Importera
IRINOTECAN ACCORDRx
Concentrate for solution for infusion, 20mg/mlAccord Healthcare Polska Sp. z o.o. Magazyn Importera
IRINOTECAN ACCORDRx
Concentrate for solution for infusion, 20mg/mlAccord Healthcare Polska Sp. z o.o. Magazyn Importera
IRINOTECAN QILURx
Concentrate for solution for infusion, 100mg/5mlKymos
IRITECRx
Concentrate for solution for infusion, 100mg/5mlVianex S.A. - Plant C
IRITECRx
Concentrate for solution for infusion, 40mg/2mlVianex S.A. - Plant C
ONIVYDE PEGYLATED LIPOSOMALRx
Concentrate for dispersion for infusion, 4.3mg/mlLes Laboratoires Servier Industrie
Source: CInMED register